Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

ATQP:GR

3.148 EUR 0.031 0.98%

As of 10:10:43 ET on 04/24/2015.

Snapshot for Vericel Corp (ATQP)

Open: 3.251 Day's Range: 3.067 - 3.347 Volume: 0
Previous Close: 3.179 52wk Range: 2.001 - 3.955 1-Yr Rtn: +10.96%

Stock Chart for ATQP

No chart data available.
  • ATQP:GR 3.347
  • 1D
  • 1M
  • 1Y
3.179
Interactive ATQP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATQP

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -0.6530
Est. PEG Ratio -
Market Cap (M EUR) 74.88
Shares Outstanding (M) 23.79
30 Day Average Volume 158
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATQP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATQP

Vericel Corp develops autologous stem/progenitor cell products for the repair/regeneration of tissues based on Tissue Repair Cell (TRC) adult stem cell technology. The Company's products contain bone marrow stem and progenitor cells that are produced from cells originating from the patient.

Dominick C Colangelo "Nick"Pres/CEO/Chief Acctg OfficerDaniel Orlando "Dan"Chief Operating Officer
Ross TuboChief Scientific OfficerDavid ReckerChief Medical Officer
More Company Profile & Key Executives for ATQP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil